Bioprocess Validation Market to Witness Significant Growth in the Coming Years
High demand for outsourcing
of bioprocess validation services and increasing R&D spending in life
science industry to drive global bioprocess validation market
According
to TechSci Research report, “Global
Bioprocess
Validation Market By Test Type (Bacterial Retention, Extractables &
Leachables, Integrity Testing, Compatibility Testing, Microbiology Testing,
Patent Safety Evaluation), By Process Component (Bioreactors, Filter Elements,
Freezing and Thawing Process Bags, Media Containers and Bags, Mixing Systems,
Transfer Systems), By End User (Contract Development & Manufacturing
Organizations (CDMO), Biotechnology, Pharmaceutical Companies), By Region,
Forecast & Opportunities, 2025”, the market is expected to undergo robust growth during the
forecast period. The market is majorly driven by presence of stringent safety
and quality regulations governing product certification and testing across
pharmaceutical and biopharmaceutical industries to maintain agreement with Good
Manufacturing Practices (GMP). Moreover, advancements in the field of
pharmaceutical manufacturing and growing requirement to reduce production cost
across pharmaceutical and food companies are acting as major growth factors for
global bioprocess validation market. Further, high demand for outsourcing of
bioprocess validation services and increasing R&D spending in life science
industry are expected to fuel the market growth through 2025.
Additionally, growing use of use of sophisticated
facilities in the pharmaceutical industry is acting as one of the key factors
for bioprocess validation market growth. Also, increasing demand for bioprocess
validation in emerging countries and patent expiries are propelling the market
growth. Further, launch of new drugs in the pharmaceutical sector are expected
to boost the growth of global bioprocess validation market in the coming years.
However, the market is also facing some challenges. Issues associated with extractable
and leachable testing are acting as restraining factor for bioprocess
validation market growth.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on "Global Bioprocess Validation Market"
https://www.techsciresearch.com/report/-bioprocess-validation-market/4928.html
The global
bioprocess validation market is segmented based on test type, process
component, end user and region. Based on test type, the market is segmented
into bacterial retention, extractables & leachables, integrity testing,
compatibility testing, microbiology testing and patent safety evaluation. Among
them, the extractables & leachables segment is anticipated to witness high
demand during the forecast period owing to presence of regulatory directives
and guidelines regarding the testing of extractables & leachables and increasing
risk of product adulterations. Moreover, growing concern related to product
safety, purity, identity and quality are also creating the demand for extractables
& leachables testing.
Based
on process component, global bioprocess validation market is segmented into bioreactors,
filter elements, freezing and thawing process bags, media containers and bags,
mixing systems and transfer systems. Among them, filter elements segment is
expected to undergo fastest growth through 2025 owing to the increasing usage
of a variety of filters in bioprocessing. Filter elements ensure the safety and
efficacy of biopharmaceutical products, which is creating their high demand in
global market.
Major players operating in the global bioprocess
validation market include Sartorius Stedim Biotech S.A., Pall Corporation,
Eurofins Scientific, SGS S.A., Cobetter Filtration Equipment Co., Ltd., Merck
KGaA, Thermo Fisher Scientific Inc., Toxikon Corporation, Meissner Filtration
Products, Inc., Doc S.R.L., Hangzhou Anow Microfiltration Co., Ltd., Almac
Group, Tianshan Precision Filter Material Co., Ltd. and Porvair plc. The
companies are investing a major portion of their sales revenue in R&D
activities. They are also focusing on launching superior quality products.
Download
Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4928
Customers
can also request for 10% free customization on this report.
“Asia
Pacific is anticipated to serve as a lucrative market for bioprocess validation
companies. The reasons can be attributed to growing biopharmaceutical
manufacturing capabilities and growing demand for outsourcing bioprocess
validation in Asian countries. The region is also witnessing an increase in
awareness about the advantages of biopharmaceutical drugs, especially in
developing nations like India and China. Apart from that, favorable government
initiatives in various APAC countries to promote the growth of pharmaceutical
& biotechnology industries is supporting the bioprocess validation market
growth,” said Mr. Karan Chechi, Research Director with TechSci Research, a
research based global management consulting firm.
“Global Bioprocess Validation Market By Test Type
(Bacterial Retention, Extractables & Leachables, Integrity Testing,
Compatibility Testing, Microbiology Testing, Patent Safety Evaluation), By Process
Component (Bioreactors, Filter Elements, Freezing and Thawing Process Bags,
Media Containers and Bags, Mixing Systems, Transfer Systems), By End User
(Contract Development & Manufacturing Organizations (CDMO), Biotechnology,
Pharmaceutical Companies), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global bioprocess
validation market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global bioprocess validation
market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]